Covista vs Perdoceo Education
CVSA and PRDO side by side, both in services-educational services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CVSA and PRDO compare
Covista is the larger company, worth 2.2 times as much as Perdoceo Education ($4.0B against $1.8B).
On earnings, Perdoceo Education is cheaper: it trades at 10.2× trailing earnings, against 16.3× for Covista.
Covista grew revenue faster over the last twelve months (9.3% versus 6.4% for Perdoceo Education).
Perdoceo Education keeps more of each dollar of sales as profit, with a net margin of 21.1% compared with 12.8% at Covista.
Perdoceo Education pays a dividend yielding 2.1%; Covista does not pay one.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CVSA | PRDO |
|---|---|---|
| Size and price | ||
| Market cap | $4.0B | $1.8B |
| Share price | $119.55 | $28.96 |
| Change, 1 year | 25.6% | −5.6% |
| Change, 5 years | 291% | 175% |
| Beta (5Y) | 0.84 | 0.67 |
| Employees | 510 | 6,000 |
| StockData Score | ||
| Total score | 18 | 18 |
| Valuation score | 3 | 4 (better) |
| Growth score | 5 (better) | 4 |
| Performance score | 5 | 6 (better) |
| Health score | 5 (better) | 3 |
| Dividend score | 0 | 1 (better) |
| Valuation | ||
| P/E | 16.3× | 10.2× (better) |
| P/S | 2.0× (better) | 2.1× |
| P/B | 2.8× | 1.7× (better) |
| EV/EBITDA | 10.7× | 4.1× (better) |
| P/FCF | 11.2× | – |
| PEG | 0.32 (better) | 0.50 |
| FCF yield | 8.9% | – |
| Fair value | $120.38 | $35.31 |
| Margin of safety | 0.69% | 18.0% (better) |
| Growth | ||
| Revenue growth (TTM) | 9.3% (better) | 6.4% |
| Revenue growth, 5Y average | 16.8% (better) | 4.2% |
| Net income growth (TTM) | 1.8% | 16.4% (better) |
| EPS growth (TTM) | 9.6% | 21.4% (better) |
| EPS growth, 5Y average | 38.9% (better) | 6.8% |
| Profitability | ||
| Gross margin | 57.4% | – |
| Operating margin | 19.8% | 24.9% (better) |
| Net margin | 12.8% | 21.1% (better) |
| FCF margin | 17.7% | – |
| Return on equity | 17.9% (better) | 17.8% |
| Return on invested capital | 17.8% | 54.8% (better) |
| Financial health | ||
| Debt / equity | 0.35 | – |
| Net debt / EBITDA | 0.70 | – |
| Interest coverage | 8.9× | 35.4× (better) |
| Current ratio | 0.81 | 4.54 (better) |
| Altman Z-score | 4.14 | 6.09 (better) |
| Piotroski F-score | 8 (better) | 7 |
| Dividends and buybacks | ||
| Dividend yield | – | 2.1% |
| Years of dividend growth | – | 2 |
| Buyback yield | 7.9% (better) | 4.9% |
| Shareholder yield | 7.9% (better) | 7.0% |
| Ownership | ||
| Held by institutions | 103% | 101% |
| Held by insiders | 3.0% | 2.3% |
| Insider net buying, 12 months | −$6.6M (better) | −$16.2M |
| Superinvestors holding | – | 1 |
| Short interest, % of float | 8.7% | 8.1% |
Go deeper
- CVSA stock overview
- CVSA income statement
- CVSA valuation and score
- PRDO stock overview
- PRDO income statement
- PRDO valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.